Clasp Therapeutics Funding & Investors
Cambridge, MA
Clasp Therapeutics offers to reach of immuno-oncology with novel precision medicines that enable the immune system to identify and specifically destroy hard-to-treat tumors bearing common driver mutations, regardless of tumor type.
clasptx.com/homeTotal Amount Raised: $150,000,000
Clasp Therapeutics Funding Rounds
Series A
$150,000,000
Series A Investors
Catalio Capital ManagementNovo HoldingsThird Rock VenturesBrightEdge FundBlackbird VenturesVivo CapitalCure VenturesPictet Alternative AdvisorsAlexandria Venture Investments
Funding info provided by Diffbot.